PF-04979064 - PI3K/mTOR Dual Inhibitor. CAS# 1220699-06-8 hylase and in vivo in monkeys

and in vivo in monkeys and humans

INCB024360 was dosed at 75 mg/Kg (BID

Fatostatin A was used at 10-20 µM in vitro

23(3):274-6

PF-04979064 - PI3K/mTOR Dual Inhibitor. CAS# 1220699-06-8 hylase and in vivo in monkeysPF 04979064, CAS No. 1220699 06 8, is a highly potent and orally bioavailable PI3K mTOR dual inhibitor developed through structure based drug design. It inhibited mTOR, PI3K, , and isoforms and AKT phosphorylation with IC50 as 2. 64 nM, 0. 395 nM, 0. 111 nM, 0. 122 nM and 28. 3 nM, respectively. PF 04979064 exhibited cellular potency with an IC50 of 9. 1 nM in a BT20 cell assay. PF 04979064 exhibited excellent in vitro potency, very good solubility,